INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, cilt.58, ss.58-64, 2017 (SCI-Expanded, Scopus)
Background: Crimean-Congo hemorrhagic fever (CCHF) is acute viral infection and a major emerging infectious diseases threat, affecting a large geographical area. There is no proven antiviral therapy and it has a case fatality rate of 4-30%. The natural history of disease and outcomes of CCHF in pregnant women is poorly understood.